Dipna Pharmachem Limited

₹4.43As of Sun 8 Nov 2026, 12:00 UTC
BSE:543594Healthcare
Country India
PE (Fwd) •••
TSR 4Y CAGR (30.13%)
Div yield —
ROE 5.22%
Drugs, Drug Proprietaries, and Druggists' Sundries
Beta (5Y) 0.06
PE TTM 4.861
TSR TTM (77.43%)
Mkt cap ₹116.5M
ROIC 4.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹5.44
22.69%
(56.61%)
Hold 2|4|3|8|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.07
0.07
0.07
0.08
(0.48%)
(12.41%)
(6.64%)
2.75%
Revenue₹M
12.18
11.88
12.38
12.54
12.62%
9.24%
9.02%
7.55%
Peers (US$1.207M)
Cap (US$)
PE
1.196M
26.75x
Capital
TTM
5Y
10Y
Leveragex
2.839
0.136
0.111
EBIT/Intx
0.456
2.854
1.996
Own earn%
(26.39)
171.96
165.06
Sh yield%
23.38
32.13
29.81
Owners
Insiders/Inst%
8.11
29.42
Short interest%
4.05
SBC / revenue%
4.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
7–11
$1 testx
0.3
Incr. ROIC%
8